Factors Associated with Acute Health Care Use in Children and Adolescents with Asthma

Dardouri, Maha; Sahli, Jihène; Ajmi, Thouraya; Mtiraoui, Ali; Bouguila, Jihéne; Mallouli, Manel

doi:10.1080/24694193.2020.1742249

Cited by 4 publications

(5 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Reproducible evidence has shown that a well-structured asthma education program improves the quality of life, reduces cost, and decreases the utilization of healthcare resources. [ 98 99 100 ] Asthma should be structured based on available resources.…”

Section: Section 5: Nonpharmacological Managementmentioning

confidence: 99%

The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children

et al. 2021

View full text Add to dashboard Cite

The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma guidelines for the diagnosis and management of asthma for adults and children, which is developed by the SINA group, a subsidiary of the Saudi Thoracic Society. The main objective of the SINA is to have guidelines that are up to date, simple to understand, and easy to use by healthcare workers dealing with asthma patients. To facilitate achieving the goals of asthma management, the SINA panel approach is mainly based on the assessment of symptom control and risk for both adults and children. The approach to asthma management is aligned for age groups: adults, adolescents, children aged 5–12 years, and children aged less than 5 years. SINA guidelines have focused more on personalized approaches reflecting better understanding of disease heterogeneity with the integration of recommendations related to biologic agents, evidence-based updates on treatment, and the role of immunotherapy in management. Medication appendix has also been updated with the addition of recent evidence, new indications for existing medication, and new medications. The guidelines are constructed based on the available evidence, local literature, and the current situation at national and regional levels. There is also an emphasis on patient–doctor partnership in the management that also includes a self-management plan.

show abstract

Section: Section 5: Nonpharmacological Managementmentioning

confidence: 99%

The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children

et al. 2021

View full text Add to dashboard Cite

show abstract

Section: Section 5: Non-pharmacological Management In Adults and Adol...mentioning

confidence: 99%

The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children

Al-Moamary,

Alhaider,

Allehebi

et al. 2023

Annals of Thoracic Medicine

View full text Add to dashboard Cite

The Saudi Initiative for Asthma 2024 (SINA-2024) is the sixth version of asthma guidelines for the diagnosis and management of asthma for adults and children that was developed by the SINA group, a subsidiary of the Saudi Thoracic Society. The main objective of the SINA is to have guidelines that are up-to-date, simple to understand, and easy to use by healthcare workers dealing with asthma patients. To facilitate achieving the goals of asthma management, the SINA Panel approach is mainly based on the assessment of symptom control and risk for both adults and children. The approach to asthma management is aligned for age groups: adults, adolescents, children aged 5–12 years, and children aged <5 years. SINA guidelines have focused more on personalized approaches reflecting a better understanding of disease heterogeneity with the integration of recommendations related to biologic agents, evidence-based updates on treatment, and the role of immunotherapy in management. The medication appendix has also been updated with the addition of recent evidence, new indications for existing medication, and new medications. The guidelines are constructed based on the available evidence, local literature, and the current situation at national and regional levels. There is also an emphasis on patient–doctor partnership in the management that also includes a self-management plan.

show abstract

“…Так, розвиток дитини в надміру оптимальних гігієнічних умовах, коли зменшу ється мікробна експозиція, може викликати чи посилювати атопічну (Th2 ) імунну відповідь у внутрішньоутробному і неонатальному періо дах розвитку дитини. Всупереч цьому, ранній контакт із мікробними компонентами може перемикати імунітет на протиінфекційний (Th1 ) шлях, зменшуючи таким чином розви ток атопічних захворювань [2,8]. Розвиткові та персистуванню атопічної і неатопічної БА сприяють вестернізація сучасного життя і зростаюча урбанізація населення [10].…”

Section: ек колоскова оа шахова си тарнавская ев власоваunclassified

“…Гіперсприйнятливість дихальних шляхів визначається як надмірне зменшення їх просві ту внаслідок надлишкової бронхоспастичної відповіді на різноманітні бронхопровокаційні стимули [20]. Під час аналізу провокаційних спірографічних проб виділяють складові ком поненти ГСБ -гіперчутливість (характеризу ється зсувом дозозалежної кривої ліворуч) і гіперреактивність, яка проявляється крутиз ною цієї кривої при її зсувах уверх [2,8]. ГСБ може варіювати в часі залежно від сили, харак теру і частоти впливів тригерних стимулів, виразності запалення дихальних шляхів, ефек тивності лікування, тяжкості БА та інших фак торів, здатних змінювати відповідь бронхів на спазмогенні стимули.…”

Section: ек колоскова оа шахова си тарнавская ев власоваunclassified

Mechanisms of formation of airway hyperreactivity in view of phenotypical heterogeneity and clinical deviation of bronchial asthma in adolescents (literature review)

Колоскова¹,

Shakhova²,

Tarnavska³

et al. 2021

MPU

View full text Add to dashboard Cite

Bronchial asthma is a disease characterized by recurrent episodes of variable bronchial obstruction, chronic bronchial inflammation, bronchial hypersensitivity and remodulation. Modern therapy of the disease was aimed at these links of pathogenesis, and this concept postulated the need for long-term use of anti-inflammatory drugs and, above all, topical inhaled corticosteroids. However, it should be recognized that the coherent inflammatory theory currently requires revision and new understanding, or even replacement with a new theory, which, considering these characteristics of the disease as an epiphenomenon, will serve as a basis for new approaches in treatment and prevention. The aim of our work — to analyze the mechanisms of formation of bronchial hyperreactivity, taking into account the phenotypic heterogeneity and clinical deviation of bronchial asthma in adolescence (based on the analysis of scientific sources). It is extremely important to determine the risk of transition of the adolescents' bronchial asthma into adulthood, when chronic obstructive pulmonary diseases might develop. Among the main predictors of this risk such factors as age, obesity, early puberty, body weight at birth and in the newborn period and sex can be distin guished. Thus, some authors associate the risk of persistence of the disease with its onset in early childhood, and others — at the age of 6 years old. High body mass index and early onset of puberty are considered to be the predictors of persistent bronchial asthma. It is noted that low and extremely low birth weight of premature infants or rapid weight gain in the neonatal period are associated with a decrease in lung ventilation and the risk of persistent asthma in the future. It is believed that bronchial asthma in children is more common in boys than in girls, in contrast, during puberty, allergic diseases and asthma are more common in girls. Conclusions. The above mentioned literature data give reason to believe that, despite advances in the scientific understanding of the pathogenesis of the main characteristics of bronchial asthma, there are great difficulties in using them in practice. Moreover, current inflammatory paradigm of bronchial asthma needs to be revised because it being a dogma becomes unproductive from a clinical point of view. No conflict of interest was declared by the authors. Key words: asthma, adolescents, hyperreactivity, remission.

show abstract

Factors Associated with Acute Health Care Use in Children and Adolescents with Asthma

Cited by 4 publications

References 20 publications

The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children

The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children

The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children

Mechanisms of formation of airway hyperreactivity in view of phenotypical heterogeneity and clinical deviation of bronchial asthma in adolescents (literature review)

Contact Info

Product

Resources

About